Pharmaceuticals stories
The funding could help turn hospital infusions into self-injectable treatments, as the London-founded firm scales microgravity drug crystallisation.
Nearly all Scottish tech firms now use AI, with full adoption doubling to 18% as sales and cashflow improve despite softer confidence.
UK patent filings drop 3.3% after three years of growth as EPO applications pass 200,000 for the first time, led by US, Germany and China.
AI tops CX investment plans, but few brands yet deploy proactive, predictive tools across channels, leaving omnichannel ambitions stalled.
Practical use, not price, is now the main hurdle for quantum AI adoption, as SAS readies a tool for Viya customers later this year.
Consumers are set to encounter AI in robots, transport and personalised shopping, as Forrester says business returns will arrive sooner than expected.
A trust-backed board majority now gives Anthropic tighter oversight as it seeks to balance rapid AI growth with its public benefit mission.
The Danish quantum software firm is pushing into life sciences now, adding senior hires and partners to sell hybrid tools before the market matures.
Pharmaceutical field teams could cut hours of searching to seconds as ACTO's new system routes approved information through compliance checks.
The hire is meant to sharpen the consultancy's North American push as clients demand clearer returns from AI and transformation spending.
Water scarcity is emerging as a constraint on AI buildouts, with a new Oxfordshire plant set to recycle most cooling water on site.
More than 180 attendees underscored rising demand for side-by-side ERP comparisons as buyers weigh cloud migration, AI and change risk.
Pharma and cold chain operators could gain faster disruption response as the two firms roll out AI tools across global supply networks.
Businesses handling sensitive content may gain a more secure option, as RWS says its new model beat DeepL in 31 of 32 languages tested.
Unsanctioned AI use is racing ahead of oversight, while many regulated organisations still leave endpoints outdated, unencrypted or unstable.
EZZ partners with JD Health to boost China supplement sales, tapping JD.com's vast digital healthcare platform for broader consumer reach.
Iran-linked wiper cyber attack cripples Stryker plants, disrupting implant production and locking thousands of staff out of global networks.
The AUD $490 million Waterloo precinct is set to ease Sydney’s lab space shortage as it moves into delivery with major global partners.
Rising storms, labour shortages and cargo fires are increasing costs and disruption for Asian shipping firms, QBE warns.
The funding will help expand Vancouver research, manufacturing and clinical trials, with hundreds of jobs and student co-op places expected to follow.